Vip Patel

Array ( [id] => 4100026 [patent_doc_number] => 06100035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Method of identifying cis acting nucleic acid elements' [patent_app_type] => 1 [patent_app_number] => 9/165794 [patent_app_country] => US [patent_app_date] => 1998-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16724 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100035.pdf [firstpage_image] =>[orig_patent_app_number] => 165794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179607 [patent_doc_number] => 06020136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Identification of functional transcription factors synthesized in developing neurons' [patent_app_type] => 1 [patent_app_number] => 9/154477 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3692 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020136.pdf [firstpage_image] =>[orig_patent_app_number] => 154477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416082 [patent_doc_number] => 06194171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Nucleic acids encoding ataxin-2 binding proteins' [patent_app_type] => 1 [patent_app_number] => 9/145391 [patent_app_country] => US [patent_app_date] => 1998-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13915 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194171.pdf [firstpage_image] =>[orig_patent_app_number] => 145391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1515423 [patent_doc_number] => 06420525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Human transcription factor ZGCL-1' [patent_app_type] => B1 [patent_app_number] => 09/137223 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21300 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420525.pdf [firstpage_image] =>[orig_patent_app_number] => 09137223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991683 [patent_doc_number] => 05985588 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Phagemid for antibody screening' [patent_app_type] => 1 [patent_app_number] => 9/135002 [patent_app_country] => US [patent_app_date] => 1998-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5296 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985588.pdf [firstpage_image] =>[orig_patent_app_number] => 135002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692606 [patent_doc_number] => 20030040038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'INDUCIBLE REGULATORY SYSTEM AND USE THEREOF' [patent_app_type] => new [patent_app_number] => 09/134793 [patent_app_country] => US [patent_app_date] => 1998-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7200 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040038.pdf [firstpage_image] =>[orig_patent_app_number] => 09134793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177556 [patent_doc_number] => 06149917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Industrial production process for a vaccine against Japanese encephalitis virus and vaccine produced' [patent_app_type] => 1 [patent_app_number] => 9/000263 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3199 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149917.pdf [firstpage_image] =>[orig_patent_app_number] => 000263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980159 [patent_doc_number] => 05958697 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Isolated nucleic acids encoding CYP7 promoter-binding factors' [patent_app_type] => 1 [patent_app_number] => 9/132619 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17788 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958697.pdf [firstpage_image] =>[orig_patent_app_number] => 132619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090232 [patent_doc_number] => 06096335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Stable particulate complexes having a lamellar, rolled, and condensed structure' [patent_app_type] => 1 [patent_app_number] => 9/126402 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10009 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096335.pdf [firstpage_image] =>[orig_patent_app_number] => 126402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154334 [patent_doc_number] => 06114154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Method of constructing full-length target cDNA molecules' [patent_app_type] => 1 [patent_app_number] => 9/118752 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7540 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114154.pdf [firstpage_image] =>[orig_patent_app_number] => 118752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213720 [patent_doc_number] => 06110738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Human fast-1 gene' [patent_app_type] => 1 [patent_app_number] => 9/113309 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 12274 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110738.pdf [firstpage_image] =>[orig_patent_app_number] => 113309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407775 [patent_doc_number] => 06228638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Escherichia coli CSRB gene and RNA encoded thereby' [patent_app_type] => 1 [patent_app_number] => 9/112584 [patent_app_country] => US [patent_app_date] => 1998-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15765 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228638.pdf [firstpage_image] =>[orig_patent_app_number] => 112584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3909835 [patent_doc_number] => 06001634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Recombinant negative strand RNA viruses' [patent_app_type] => 1 [patent_app_number] => 9/106377 [patent_app_country] => US [patent_app_date] => 1998-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 33723 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001634.pdf [firstpage_image] =>[orig_patent_app_number] => 106377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192222 [patent_doc_number] => 06153729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Isolated nuclear matrix targeting peptide' [patent_app_type] => 1 [patent_app_number] => 9/100193 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18344 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153729.pdf [firstpage_image] =>[orig_patent_app_number] => 100193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158759 [patent_doc_number] => 06103877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Tumor suppressor gene, HIC-1' [patent_app_type] => 1 [patent_app_number] => 9/085407 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 18287 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103877.pdf [firstpage_image] =>[orig_patent_app_number] => 085407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4300239 [patent_doc_number] => 06251628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Isolated nucleic acid molecules encoding Smad7' [patent_app_type] => 1 [patent_app_number] => 9/082092 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 70 [patent_no_of_words] => 31950 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251628.pdf [firstpage_image] =>[orig_patent_app_number] => 082092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171315 [patent_doc_number] => 06083721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Isolated nucleic acid molecules encoding PARG, a GTPase activating protein which interacts with PTPL1' [patent_app_type] => 1 [patent_app_number] => 9/080855 [patent_app_country] => US [patent_app_date] => 1998-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 29575 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083721.pdf [firstpage_image] =>[orig_patent_app_number] => 080855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245021 [patent_doc_number] => 06136598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Mus dunni endogenous retroviral packaging cell lines' [patent_app_type] => 1 [patent_app_number] => 9/075272 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25029 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136598.pdf [firstpage_image] =>[orig_patent_app_number] => 075272 [rel_patent_id] =>[rel_patent_doc_number] =>)